Research reveals COVID-19’s lasting impact on brain function and structure

Study investigates post-COVID-19 cognitive defects, finding that SARS-CoV-2 infections are linked to brain injury markers and reduced cingulate cortex volume, with corticosteroids offering some cognitive protection.

Pharmalittle: We’re reading about Sanders and Novo Nordisk CEO sparring, Roche refocusing, and more

Hello, everyone, and how are you today? We are doing just fine, thank you, and given that the middle of the week is here, we

September 25, 2024

Eli Lilly boosts 2024 revenue guidance by $3 billion on Mounjaro, Zepbound sales

Eli Lilly raised its full-year revenue guidance by $3 billion, driven by massive sales of its GLP-1-based diabetes and obesity drugs Mounjaro and Zepbound. The

August 8, 2024

AI System Beats Radiologists in Detecting Clinically Significant Prostate Cancer

An artificial intelligence (AI) system was better at detecting clinically significant prostate cancer on MRI compared with radiologists, a noninferiority, confirmatory study showed. In a

June 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.